159 related articles for article (PubMed ID: 37537688)
1. Promoter hypermethylation of neural-related genes is compatible with stemness in solid cancers.
Idris M; Coussement L; Alves MM; De Meyer T; Melotte V
Epigenetics Chromatin; 2023 Aug; 16(1):31. PubMed ID: 37537688
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly hypermethylated tumor suppressor genes were identified in oral squamous cell carcinoma (OSCC).
Kim SY; Han YK; Song JM; Lee CH; Kang K; Yi JM; Park HR
Clin Epigenetics; 2019 Aug; 11(1):116. PubMed ID: 31405379
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of RUNX3 in microsatellite unstable sporadic colon cancers.
Goel A; Arnold CN; Tassone P; Chang DK; Niedzwiecki D; Dowell JM; Wasserman L; Compton C; Mayer RJ; Bertagnolli MM; Boland CR
Int J Cancer; 2004 Dec; 112(5):754-9. PubMed ID: 15386381
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation profiling revealed promoter hypermethylation-induced silencing of p16, DDAH2 and DUSP1 in primary oral squamous cell carcinoma.
Khor GH; Froemming GR; Zain RB; Abraham MT; Omar E; Tan SK; Tan AC; Vincent-Chong VK; Thong KL
Int J Med Sci; 2013; 10(12):1727-39. PubMed ID: 24155659
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation.
Roll JD; Rivenbark AG; Sandhu R; Parker JS; Jones WD; Carey LA; Livasy CA; Coleman WB
Exp Mol Pathol; 2013 Dec; 95(3):276-87. PubMed ID: 24045095
[TBL] [Abstract][Full Text] [Related]
6. Identification of regulatory role of DNA methylation in colon cancer gene expression via systematic bioinformatics analysis.
Yang Y; Chu FH; Xu WR; Sun JQ; Sun X; Ma XM; Yu MW; Yang GW; Wang XM
Medicine (Baltimore); 2017 Nov; 96(47):e8487. PubMed ID: 29381923
[TBL] [Abstract][Full Text] [Related]
7. A genome-wide search identifies epigenetic silencing of somatostatin, tachykinin-1, and 5 other genes in colon cancer.
Mori Y; Cai K; Cheng Y; Wang S; Paun B; Hamilton JP; Jin Z; Sato F; Berki AT; Kan T; Ito T; Mantzur C; Abraham JM; Meltzer SJ
Gastroenterology; 2006 Sep; 131(3):797-808. PubMed ID: 16952549
[TBL] [Abstract][Full Text] [Related]
8. A global profile of gene promoter methylation in treatment-naïve urothelial cancer.
Ibragimova I; Dulaimi E; Slifker MJ; Chen DY; Uzzo RG; Cairns P
Epigenetics; 2014 May; 9(5):760-73. PubMed ID: 24521710
[TBL] [Abstract][Full Text] [Related]
9. A DNA hypermethylation module for the stem/progenitor cell signature of cancer.
Easwaran H; Johnstone SE; Van Neste L; Ohm J; Mosbruger T; Wang Q; Aryee MJ; Joyce P; Ahuja N; Weisenberger D; Collisson E; Zhu J; Yegnasubramanian S; Matsui W; Baylin SB
Genome Res; 2012 May; 22(5):837-49. PubMed ID: 22391556
[TBL] [Abstract][Full Text] [Related]
10. DNA methylation instability by BRAF-mediated TET silencing and lifestyle-exposure divides colon cancer pathways.
Noreen F; Küng T; Tornillo L; Parker H; Silva M; Weis S; Marra G; Rad R; Truninger K; Schär P
Clin Epigenetics; 2019 Dec; 11(1):196. PubMed ID: 31842975
[TBL] [Abstract][Full Text] [Related]
11. Histone H3 lysine 27 trimethylation in adult differentiated colon associated to cancer DNA hypermethylation.
Rada-Iglesias A; Enroth S; Andersson R; Wanders A; Påhlman L; Komorowski J; Wadelius C
Epigenetics; 2009 Feb; 4(2):107-13. PubMed ID: 19276669
[TBL] [Abstract][Full Text] [Related]
12. Changes in correlation between promoter methylation and gene expression in cancer.
Moarii M; Boeva V; Vert JP; Reyal F
BMC Genomics; 2015 Oct; 16():873. PubMed ID: 26510534
[TBL] [Abstract][Full Text] [Related]
13. Promoter hypermethylation in male breast cancer: analysis by multiplex ligation-dependent probe amplification.
Kornegoor R; Moelans CB; Verschuur-Maes AH; Hogenes MCh; de Bruin PC; Oudejans JJ; van Diest PJ
Breast Cancer Res; 2012 Jul; 14(4):R101. PubMed ID: 22765268
[TBL] [Abstract][Full Text] [Related]
14. Impact of mutations in DNA methylation modification genes on genome-wide methylation landscapes and downstream gene activations in pan-cancer.
Lee CJ; Ahn H; Jeong D; Pak M; Moon JH; Kim S
BMC Med Genomics; 2020 Feb; 13(Suppl 3):27. PubMed ID: 32093698
[TBL] [Abstract][Full Text] [Related]
15. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of tumor-related genes in the progression of colorectal neoplasia.
Bai AH; Tong JH; To KF; Chan MW; Man EP; Lo KW; Lee JF; Sung JJ; Leung WK
Int J Cancer; 2004 Dec; 112(5):846-53. PubMed ID: 15386372
[TBL] [Abstract][Full Text] [Related]
17. Defining a chromatin pattern that characterizes DNA-hypermethylated genes in colon cancer cells.
McGarvey KM; Van Neste L; Cope L; Ohm JE; Herman JG; Van Criekinge W; Schuebel KE; Baylin SB
Cancer Res; 2008 Jul; 68(14):5753-9. PubMed ID: 18632628
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array.
Fang WL; Chen MH; Huang KH; Chang SC; Lin CH; Chao Y; Lo SS; Li AF; Wu CW; Shyr YM
Clin Epigenetics; 2019 Nov; 11(1):154. PubMed ID: 31675985
[TBL] [Abstract][Full Text] [Related]
19. Promoter hypermethylation of the 14-3-3 sigma, SYK and CAGE-1 genes is related to the various phenotypes of urinary bladder carcinomas and associated with progression of transitional cell carcinomas.
Kunze E; Wendt M; Schlott T
Int J Mol Med; 2006 Oct; 18(4):547-57. PubMed ID: 16964403
[TBL] [Abstract][Full Text] [Related]
20. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.
Jacinto FV; Ballestar E; Ropero S; Esteller M
Cancer Res; 2007 Dec; 67(24):11481-6. PubMed ID: 18089774
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
